Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

Friday, July 29, 2016
close

Top Medical News from Across Medscape

  • FDA Approves Lixisenatide (Adlyxin) for Type 2 DiabetesThe latest GLP-1 agonist for the treatment of type 2 diabetes to gain approval in the US is lixisenatide; it's already approved under the brand name Lyxumia in more than 60 countries.
  • Induced Labor Not Linked to ASDNo relationship was seen between labor induction and an increased risk for ASD when exposure-discordant sibling or cousin pairs were compared to account for familial factors, authors said.

Special Report

  • There is controversy surrounding the VA's proposed rule on independent practice for APRNs. Learn about the views of professional organizations, see what the research shows, and learn how clinicians find ways to practice together.

Business of Medicine

  • HPV Vaccines Work, So Why Aren't Doctors Recommending Them?   Many women die each year from preventable cervical cancer, yet doctors aren't urging their younger patients to get vaccinated--possibly to avoid awkward discussions about STDs, an ethicist says.
  • How to Negotiate the Best Raise Possible Physicians may be leery of pressing for better pay or more perks. But doing so the right way could help make a strong case for more money.

Medscape Editor-in-Chief

  • Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.